Assignment: Noncompliant Patient
Assignment: Noncompliant Patient
Assignment: Noncompliant Patient
Week 6 midterm
Question 1
A noncompliant patient states, Why do you want me to put this poison in my body? Identify the best response made by the psychiatric-mental health nurse practitioner (PMHNP).
Question 2
Which statement about neurotransmitters and medications is true?
Question 3
When an unstable patient asks why it is necessary to add medications to his current regimen, the PMHNPs best response would be:
Question 4
During gene expression, what must occur prior to a gene being expressed?
Question 5
While genes have potential to modify behavior, behavior can also modify genes. How do genes impact this process?
Question 6
Though medications have the ability to target neurotransmitters in the synapse, it is not always necessary. The PMHNP understands that this is because:
Question 7
Why is the cytochrome P450 enzyme system of significance to the PMHNP?
Question 8
It is important for the PMHNP to recognize differences in pharmacokinetics to safely prescribe and monitor medications. Which of the following statements does the competent PMHNP identify as true?
Question 9
As it relates to G-protein linked receptors, what does the PMHNP understand about medications that are used in practice?
Question 10
The PMHNP is considering prescribing a 49-year-old male clozapine (Clozaril) to treat his schizophrenia and suicidal ideations. The PMHNP is aware that which factor may impact the dose needed to effectively treat his condition:
Question 11
A patient is diagnosed with bipolar disorder and is currently taking carbamazepine (Tegretol), aripiprazole (Abilify), and melatonin. The PMHNP has just written an order to discontinue the carbamazepine (Tegretol) for drug-induced thrombocytopenia. The PMHNP is aware that his next best action is to:
Question 12
A patient recently transferred following a suicide attempt has a history of schizophrenia, depression, and fibromyalgia. He is currently taking Amitriptyline (Elavil), Lisinopril, aspirin, and fluoxetine (Prozac). Which is the best action for the PMHNP to take for this patient?
Question 13
A patient with schizophrenia is given an inverse agonist that acts on the receptor 5HT and neurotransmitter serotonin. What is the rationale for prescribing a medication such as this?
Question 14
The PMHNP is caring for four patients. Which patient statement indicates that benzodiazepines would be beneficial?
Question 15
Ms. Harlow is a 42-year-old patient who is prescribed a drug that acts on ionotropic receptors. She is curious about the effects of the drug and how it will act on her symptoms. Which statement made by the PMHNP demonstrates proper understanding of Ms. Harlows prescription?
Question 16
A patient is seeking pharmacological treatment for smoking cessation. Which drug class does the PMHNP prescribe to the patient?
Question 17
The PMHNP is caring for a new patient who has been transferred from another office. When meeting with the new patient, the patient reports, I feel like I am improving with the stabilizers. The PMHNP immediately recognizes that the patient is describing which kind of drug?
Question 18
A patient presents with frequent episodes of mania. Which statement describes an appropriate treatment approach for this patient?
Question 19
The PHMNP is caring for a patient who would benefit from nicotine cholinergic, serotonin 3, or glycine receptors. What kind of agent does the PHMNP want to prescribe for this patient?
Question 20
Which statement made by the patient suggests the patient will need to be treated with antipsychotics that target paranoid psychosis?
Question 21
A patient has been treated with a number of novel psychotropic drugs. How is it theoretically possible to identify cognitive improvement in the patient using neuropsychological assessment batteries after the pharmacologic therapy?
Question 22
Mr. McCullin is 64 years old with Parkinsons disease. The PMHNP caring for Mr. McCullin wants to start him on a dopamine agonist to help manage and treat his condition. The PHMNP selects this agent because of which action it has on patients like Mr. McCullin?
Question 23
Mrs. Trevor is a 44-year-old patient who does not have a diagnosis of schizophrenia but occasionally reports symptoms of psychosis, followed by severe fatigue. Mrs. Trevor inquires about the use of amphetamines to help with her energy levels. Which response made by the PMHNP is most appropriate?
Question 24
The PMHNP is caring for a patient with schizophrenia and is considering a variety of treatment approaches. The PHMNP selects a viable treatment that is consistent with the dopamine hypothesis of schizophrenia. What action does the PMHNP anticipate this treatment having on the patient?
Question 25
A patient is diagnosed with schizophrenia. What increases the patients potential to mediate the cognitive symptoms of the disease?
Question 26
The PMNHP is assessing a 29-year-old patient who takes antipsychotics that block D2 receptors. What patient teaching should the PMHNP include related to the possible side effects of this type of drug?
Question 27
The PMHNP is caring for a patient who is taking antipsychotics heard the psychiatrist tell the patient that the patient would be placed on a different antipsychotic agent. Which of the following requires the longest transition time for therapeutic benefit?
Question 28
The PMHNP is assessing a patient who has cirrhosis of the liver and anticipates that the patient will be prescribed an antipsychotic. Which medication does the PMHNP suspect will be ordered for this patient?
Question 29
Which statement made by the PMHNP exemplifies correct teaching of physiological effects in the body?
